The Korean pharmaceutical industry continues to expand its investment in R&D each year to boost the development of new medicines. Korean pharmaceutical companies have more than 900 new medicines currently in the pipeline and this number accounts for 4% of the total pipelines in the world.
| Contact Details | Room 417, Building A, Samhwan Hypex, 240 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-doTEL: 02-489-3611E-MAIL: union@ukp.co.kr |
|---|
